Sign in
Taking peopleNo phase

Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

Key facts

Who runs it
Dong-A ST Co., Ltd.
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
5,000 people, planned
Started
8 Feb 2021
Expected to end
Feb 2035
Type of study
Observational
Record updated
21 July 2026

Who can take part

The trial is looking for children with short stature who are treated with Growtropin®-II. It follows how safe and effective this growth hormone is over a long time.

Age
2 Years and older
Sex
All
Disease stage
Short stature caused by growth hormone deficiency (GHD), idiopathic short stature (ISS, short stature with no known cause), Turner syndrome (TS) or being born small for gestational age (SGA).
Main reasons for not taking part
  • Children whose growth plates in the bones have closed (epiphyseal closure)
  • Children without an official height record from at least 6 months before
Show the full registry criteria (3)Hide the full registry criteria

Who can take part

  • Children with short stature by growth hormone deficiency(GHD) or idiopathic short stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA)
  • Children who has official height record at least 6 months prior

Who cannot take part

  • Children with Epiphyseal closure

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age

This trial is currently available in South Korea.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.

The group in the trial

  • Growth hormone

    Growtropin®-II

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Open, Multi-center, Non-interventional, Prospective/ Retrospective Observational Study on Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT04798690, who can take part
Record updated
21 July 2026